Skip to content

Clinical trials

Phase 1/2 Small Cell Lung Carcinoma trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Small Cell Lung Carcinoma Phase: Phase 1/2 Country / region: Italy Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20091
20172
20201
20211
20252
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting5
Completed2
Terminated2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie1
Armando Santoro, MD1
BioNTech SE1
Bristol-Myers Squibb1
MediLink Therapeutics (Suzhou) Co., Ltd.1
Merck Sharp & Dohme LLC1
Mundipharma Research Limited1
National Cancer Institute, Naples1
Novartis Pharmaceuticals1
PMV Pharmaceuticals, Inc1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Small Cell Lung Carcinoma10
Breast Neoplasms3
Carcinoma, Non-Small-Cell Lung2
Endometrial Neoplasms2
Neoplasm Metastasis2
Ovarian Neoplasms2
Triple Negative Breast Neoplasms2
Colorectal Neoplasms1
Fallopian Tube Neoplasms1
Gallbladder Neoplasms1

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.